0001954975-22-000001.txt : 20221117 0001954975-22-000001.hdr.sgml : 20221117 20221117141626 ACCESSION NUMBER: 0001954975-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221117 DATE AS OF CHANGE: 20221117 EFFECTIVENESS DATE: 20221117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AME Therapeutics, Inc. CENTRAL INDEX KEY: 0001954975 IRS NUMBER: 863806621 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-465106 FILM NUMBER: 221397739 BUSINESS ADDRESS: STREET 1: 3130 WILSHIRE BLVD., #600 CITY: SANTA MONICA STATE: CA ZIP: 90403 BUSINESS PHONE: 310-789-5202 MAIL ADDRESS: STREET 1: 3130 WILSHIRE BLVD., #600 CITY: SANTA MONICA STATE: CA ZIP: 90403 D 1 primary_doc.xml X0708 D LIVE 0001954975 AME Therapeutics, Inc. 3130 WILSHIRE BLVD., #600 SANTA MONICA CA CALIFORNIA 90403 310-789-5202 DELAWARE None None Corporation true 2021 Michael Einziger 3130 Wilshire Blvd., #600 Santa Monica CA CALIFORNIA 90403 Executive Officer Director Ann Marie Simpson 3130 Wilshire Blvd., #600 Santa Monica CA CALIFORNIA 90403 Director Other Decline to Disclose 06b false 2021-06-08 true true Simple Agreements for Future Equity false 0 1072500 1072500 0 false 12 0 0 0 false AME Therapeutics, Inc. /Michael Einziger/ Michael Einziger President 2022-11-01